Place your BETs: the therapeutic potential of bromodomains
被引:174
作者:
Prinjha, R. K.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline PLC, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, EnglandGlaxoSmithKline PLC, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, England
Prinjha, R. K.
[1
]
Witherington, J.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline PLC, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, EnglandGlaxoSmithKline PLC, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, England
Witherington, J.
[1
]
Lee, K.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline PLC, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, EnglandGlaxoSmithKline PLC, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, England
Lee, K.
[1
]
机构:
[1] GlaxoSmithKline PLC, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, England
Therapeutic targeting of the processes that regulate histone modification is a growing area of scientific exploration. Although most interest has concentrated on the various families of enzymes that contribute to these processes, this review focuses on emerging data demonstrating the chemical tractability and therapeutic potential of a hitherto underexplored family of proteins, namely the bromodomain (BRD) family of reader proteins. These proteins perform a crucial role in translating histone modifications with powerful transcriptional consequences. We review current knowledge of the biology of this emergent target class and highlight recent breakthroughs that now make the BRD family of reader proteins attractive for drug discovery.